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Ecotropic and xenotropic murine leukemia viruses (MuLV's) constitute sepa-
rate interference groups; within each group there is cross-interference, but
between the groups there is no detectable interference. Interference is manifest
against pseudotypes in which the vesicular stomatitis virus genome is contained
within the coat of one of the murine leukemia viruses. The pseudotypes display
the cell specificity of the leukemia viruses: pseudotypes with an ecotropic MuLV
coat infect mouse cells but not rabbit or mink cells; pseudotypes with a xeno-
tropic MuLV coat infect rabbit or mink cells well but mouse cells very poorly.
Efficient pseudotype formation also occurs between the two MuLV classes, and
both the interference patterns and the cell specificity of these pseudotypes are
entirely determined by their envelope. Using these pseudotypes, ecotropic
MuLV infection could be established in xenogeneic cells, and the resulting
progeny could be scored by using a conventional XC cell assay. Also, xenotropic
MuLV infection could be established in a mouse cell, showing that no absolute
intracellular barrier against xenotropic virus growth exists in murine cells. The
major barriers against both xenotropic and ecotropic MuLV therefore are cell
surface barriers. Xenogeneic cells probably lack receptors for ecotropic MuLV,
but murine cells may either lack receptors for xenotropic MuLV or have recep-
tors that are blocked by endogenous expression ofthe glycoprotein of endogenous
xenotropic MuLV.
The host range of RNA tumor viruses is de-
termined by a composite of surface receptor
specificities and intracellular restriction phe-
nomena. For avian and feline viruses, the ma-
jor characterized determinant of cell suscepti-
bility is the specificity of cell surface receptors;
the best-characterized determinant of the host
range of murine leukemia viruses (MuLV) is
the Fv-1 gene product, which causes an intra-
cellular restriction (18, 21, 22).
There is a class of endogenous mouse viruses
that are unable to infect mouse cells; they have
been called xenotropic viruses because they can
infect the cells of other animal species (2, 5, 23,
26). From work on interspecies hybrid cells, it
has been suggested that the barrier to infection
of mouse cells by these viruses is an intracellu-
lar restriction (14, 33). Using several methods,
we have investigated whether there might be a
barrier at the cell surface. First, we have deter-
mined cross-interference patterns of the xeno-
tropic and ecotropic MuLV's and have shown
that mouse-tropic (ecotropic) murine viruses in-
terfere with each other because they all use the
same receptors. However, the xenotropic vi-
ruses were found not to interfere with ecotropic
viruses, suggesting that the xenotropic viruses
cannot absorb to the receptor for ecotropic vi-
rus. Second, we have made pseudotypes of ve-
sicular stomatitis virus (VSV) having the coat
of xenotropic MuLV. These pseudotypes did not
penetrate mouse cells but did penetrate rabbit
cells, showing that no functional receptor for
xenotropic murine leukemia virus exists on fi-
broblastic murine cells. In a similar fashion, it
was shown that ecotropic MuLV's do not pene-
trate rabbit and mink cells. Finally, we have
produced pseudotypes in which an ecotropic ge-
nome is found in a xenotropic coat, and vice
versa. In both cases the tropism is determined
by the coat, allowing establishment of an infec-
tion of a xenotropic virus in mouse cells and an
ecotropic virus in mink cells.
To simplify description of these experiments,
we have adopted the nomenclature of MuLVE
and MuLVx to designate ecotropic and xeno-
tropic MuLV's, respectively.
MATERIALS AND METHODS
Cells and leukemia viruses. The designation and
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origin of each of the viruses used in this study are
given in Table 1. The description of the cell lines
used here is given in Table 2.
NIH/3T3 cells were a gift of S. A. Aaronson (Na-
tional Institutes of Health [NIH]). JLS-V9 cells were
obtained from Ken Manly (Roswell Park Memorial
Institute). The rabbit cell line (SIRC) was obtained
from G. Todaro (National Cancer Institute). XC
cells were provided by J. Hartley (NIH). NIH cells
producing Moloney MuLV (M-MuLV) clone 1 virus
were derived in this laboratory (11). The 15176 cell
line producing murine sarcoma virus (MSV) and
MuLVx was kindly provided by J. Levy. SIRC cells
producing the MuLVx from BALB/c cells are the end
point of a titration of bromodeoxyuridine (BUdR)-
induced virus from JLS-V9 cells (6). NIH cells pro-
ducing the endogenous N-tropic virus from JLS-V9
TABLE 1. Murine leukemia virus nomenclature
Designation Characteristics
MuLVE Any MuLV able to grow on some mouse
cells.
MuLVx Any MuLV unable to grow on mouse
cells but able to grow on cells of other
species.
IN-MuLV N-tropic MuLV recovered after induction
of JLS-V9 cells with IUdR, cloned on
NIH/3T3 cells. Makes small plaques
(11).
N-C1-35-MuLV N-tropic MuLV derived from BALB/c an-
imals and cloned (20).
B-C1-11-MuLV B-tropic MuLV derived from BALB/c an-
imals and cloned (20).
M-MuLV Clone 1 Moloney MuLV. NB-tropic (11).
MuLVxa Subclass of xenotropic MuLV that previ-
ously was designated Xa by Callahan
et al. (7) and as class II MuLV by
Aaronson and Stephenson (3).
MuLVXb Subclass of xenotropic MuLV that previ-
ously was designated Xb by Callahan
et al. (7) and as class III MuLV by
Aaronson and Stephenson (3). MuLVXb
differs from MuLVxa by nucleic acid
sequences and the immunological type
specificity in the structural protein
p12.
TABLE 2. Origin of cell lines
Cells Species of origin Reference
JLS-V9 Mouse (BALB/c) 45
NIH/3T3 Mouse (NIH Swiss; Fv- 19
NRK Rat 9
SIRC Rabbit 5
Cat S+L- (sub- Cat (transformed by M- 12
clone 81) MSV)
CCL64 Mink 16
XC Rat (transformed by 40
Rous sarcoma virus)
SIM.R Mouse (Swiss inbred; Fv- 42
lblb)
15176 Human [infected with J. Levy (per-
MSV(MuLVXb)] sonal com-
munica-
tion)
cells were obtained by infecting NIH/3T3 cells with
virus from BUdR-induced JLS-V9 cells (6). The 8c
subclone 81, a sarcoma-positive, leukemia-negative
(S+L-) cat cell line transformed by M-MSV, was
kindly provided by P. Fischinger. The mink cell
line, CCL64, was obtained from the American Type
Culture Collection. NRK cells were obtained from
D. Livingston, and SIM.R cells were provided by A.
Axelrad.
Cells were grown in Dulbecco modified Eagle me-
dium with 10% calf serum (NIH/3T3, SIRC, XC) or
with 10% heat-inactivated fetal calf serum (JLS-V9,
15176, CCL64, and SIM.R). The cat S+L- cells were
grown in McCoy 5A medium plus 14% heat-inacti-
vated fetal calf serum.
Induction with halogenated pyrimidines. On the
day after plating of 5 x 105 cells/plate, the medium
was changed to medium containing 20 ,ug of BUdR
or iododeoxyuridine (IUdR) and 25 ,ug of deoxycyti-
dine per ml. (27). After 20 to 24 h, the BUdR- or
IUdR-containing medium was removed, and the
plates were washed once with regular medium.
Peak virus production occurs 1.5 to 3 days after
removal of the BUdR- or IUdR-containing medium
(6).
MuLV infections. Approximately 1 x 105 to 2 x
105 cells were seeded onto a 60-mm dish. Twenty-
four hours later the cells were inoculated with 0.5 ml
of the virus sample in medium containing 8 ,ug of
polybrene per ml. After 2 h of adsorption, 5 ml of
regular medium was added. The XC plaque assay
with NIH/3T3 as indicator cells was used for quanti-
tation of MuLVE (31). For quantitation of MuLVx, a
focus assay described by Fischinger et al. (12) was
used.
VSV. VSV wild type (Indiana serotype) was
kindly provided by A. S. Huang (35). A cloned stock
of the VSV mutant tl 17 was provided by R. Weiss
and J. Zavada. This mutant has a thermolabile en-
velope glycoprotein and is easily inactivated at 45°C
(47).
VSV titration was carried out as described earlier
(34). To produce VSV pseudotypes with a MuLV coat
[VSV(MuLV)], subconfluent cells were infected
with a 1-ml (per 10-cm plate) virus inoculum in
Dulbecco modified Eagle medium (multiplicity of
infection of 2 to 5). After 1 h of adsorption at 32 or
37°C for VSV tl17 or VSV wild type, respectively,
the unadsorbed virus was washed off two times and
regular medium was added back. After 12 to 15 h of
incubation at 32 or 37°C, respectively, the superna-
tant was collected and cell debris was removed by
low-speed centrifugation. Heat inactivation was
carried out at 45°C (+0.2°C) for 1 h or as indicated.
Neutralizations. Anti-M-MuLV serum from tu-
mored Fischer rats was provided by the Virus Can-
cer Program. Rabbit neutralizing antiserum against
VSV was provided by A. S. Huang, and rabbit anti-
serum made against NZB-MuLVx was provided by
Jay Levy.
VSV antiserum was used at a final concentration
of 1:20 if not otherwise indicated. A virus sample of
0.5 ml was mixed with 0.5 ml of VSV antiserum in
phosphate-buffered saline. The neutralizations with
the MuLVx antiserum were done at a final antibody
J. VIROL.
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concentration of 1:20. Controls contained equal vol-
umes of virus and phosphate-buffered saline. The
samples were incubated for 1 h at 370C. Neutraliza-
tions with antiserum made against M-MuLV were
done at a final antibody concentration of 1:40. At the
concentration used in these experiments, this anti-
serum neutralizes M-MuLV to less than 10-5.
RESULTS
Interference among ecotropic viruses. Ex-
isting data suggest that all MuLVE cross-inter-
fere (32). We have tested this generality for two
very different MuLVE strains. One is an N-
tropic virus, IN-MuLV, that makes turbid
small XC cell plaques. The other is M-MuLV, a
virus that makes large XC cell plaques and is
NB-tropic. The plaque morphology marker al-
lowed the two viruses to be distinguished.
When uninfected NIH/3T3 cells and NIH/3T3
cells preinfected with IN-MuLV were exposed
to M-MuLV, the preinfected cells produced a
yield after 5 days that was 10-3 ofthe yield from
uninfected cells (Table 3). An XC cell titration
of M-MuLV on either NIH/3T3 or NIH/3T3
preinfected with IN-MuLV showed a titer of 106
PFU/ml on NIH/3T3 cells and no M-MuLV
plaques on the preinfected cells. These two dif-
ferent assays indicate a strong interference be-
tween the two viruses.
To investigate whether the interference
among MuLVE strains was a surface interfer-
ence, VSV(M-MuLV) was produced by infect-
ing M-MuLV-producing cells with the heat-la-
bile VSV t117. The VSV(VSV) in the stock was
then killed by heating at 450C (47; Fig. 1).
Neutralization of the heat-inactivated samples
TABLE 3. Interference of MuLVE-producing cells
with M-MuLV
(A) Superinfection with M-MuLV and determination of M-
MuLV yield
Cells PFU/ml after 5 days
NIH 4 x 106
NIH(IN-MuLV) 4 x 103
(B) Superinfection with VSVt117(M-MuLV)
PFU/ml after given an-
tibody treatment Ratio
Cells none/anti-
Anti-M- M-MuLV
None MuLV
NIH 1.8x 105 1.4 x 102 1.3 x 103
NIH(N-C1-35- 8 x 101 9 x 101 0.9
MuLV)
NIH(IN-MuLV) 1.1 x 103 6 x 102 1.8
JLS-V9 1.4x 105 3 x !0' 4.7 x 103
JLS-V9(M-MuLV) 5 x 102 1.2 x 102 4.2
JLS-V9(B-C1-11- 4 x 102 3 x 102 1.3
MuLV)
V/,VO
10 ,
30 60
Minutes inactivation at 45° C
FIG. 1. Preparation and characterization of VSV
til 7(M-MuLVE). M-MuLVE-producing clone 1 cells
were infected with VSV t117 at 32°C at a multiplicity
of infection of 1 to 2. The virus was adsorbed in a
volume of 0.5 ml per 5-cm dish. After 45 min of
adsorption, 4 ml ofmedium was added to the culture.
After 14 h of incubation at 32°C, the virus yield was
harvested and aliquots were heat inactivated for dif-
ferent lengths of time at 45°C. The residual fraction
ofVSV was then determined in a VSV plaque assay
on NIHI3T3 cells at 32°C (@). Some samples that
had been inactivated at 45°C were also neutralized
with antiserum made against M-MuLV as indicated
in Materials and Methods, and the remaining frac-
tion of VSV was determined as described above (A).
with anti-M-MuLV antibody further decreased
the remaining fraction 1,000-fold. The fraction
that can be neutralized with M-MuLV antisera
after heat inactivation is composed of the
VSV(M-MuLV) pseudotypes (Fig. 1). The
VSV(M-MuLV) produced in this way was used
to infect control mouse cells and mouse cells
preinfected with various MuLVE strains (Table
3). Different uninfected cell lines show as much
as 10-fold variation in intrinsic susceptibility to
VSV. To control this variability, the VSV(M-
MuLV) pseudotypes were assayed before and
after neutralization with an anti-M-MuLV an-
tiserum. Positive pseudotype susceptibility was
indicated by at least a 100-fold drop in titer
after antiserum treatment.
VSV(M-MuLVE) could infect normal mouse
cells as previously reported (18, 30, 46) but
could not infect the cells previously infected
with MuLVE (Table 3). Therefore, the MuLVE
strains tested all cross-interfere at the cell sur-
face, suggesting that they use the same recep-
tor-penetration mechanism.
Interference between a xenotropic virus
and an ecotropic virus. Although MuLVx does
not infect mouse cells, it might be able to block
the surface receptor used by MuLVE. To test
such a possibility, a mouse cell line producing a
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high titer of MuLVx was infected with a
MuLVE. The cells used were JLS-V9 cells in-
duced with IUdR. Although untreated JLS-V9
cells produced no detectable MuLVx, the in-
duced cells produced 104 to 3 x 105 infectious
particles per ml of MuLVx as determined by
end-point dilutions on rabbit (SIRC) and rat
(NRK) cells or by focus assay on cat S+L- cells
(Table 4). By supernatant DNA polymerase as-
say, IUdR-induced cells produced almost as
much virus as the best MuLVE-producing cell
lines (6). The induced cells also produced a low
amount of N-tropic MuLVE detected by end-
point dilution on NIH/3T3 cells (Table 4), but
no detectable B-tropic virus (6). Induced and
uninduced JLS-V9 cells were infected with M-
MuLVE at a multiplicity of infection of 0.5, and
the M-MuLVE yield was determined by XC as-
say 40 h after infection. The induced cells pro-
duced 2.4-fold less M-MuLVE than did the unin-
duced cells (Table 5). This should be compared
with the 1,000-fold difference produced by
preinfection of cells with MuLVE (Table 3A)
and suggests that MuLVx interferes, at most,
slightly with MuLVE. The lack of interference
between MuLVx and MuLVE was confirmed by
titering VSV(M-MuLVE) on uninduced and
BUdR-induced JLS-V9 cells; again the induced
cells gave only a slightly lower titer of VSV
(Table 5). The twofold difference between in-
duced and uninduced cells seen in these assays
TABLE 4. Host range of the induced viruses from
JLS-V9 cellsa
Cells Infectious units/ml FFUs/ml
NIH/3T3 2 x 101 -
NRK 1 x 104 -
SIRC 1 x 105 -
Cat S+L- - 3 x 105
a Infectious units were determined by end-point
dilutions on the indicated lines and DNA polymer-
ase assays of the supernatant fluids from the in-
fected cultures (6). FFU were determined as by
Fischinger et al. (12).
TABLE 5. Lack of interference of MuLVx-producing
cells with M-MuLVE
Yield or titer (PFU/ml) after superin-
fection with:a
Cells
M-MuLV VSV(M-MuLV)pseudotypes
JLS-V9 8.6 x 106 3.5 x 105
IUdR-treated 3.5 x 106 1.4 x 105
JLS-V9
a For M-MuLV, yield was determined 40 h after
infection of the indicated cells; for VSV(M-MuLV),
the indicated cells were used to titer a pseudotype
preparation.
J. VIROL.
could have been a result of the small amount of
IN-MuLVE produced by the induced cells or
could have been a result of toxicity. Whatever
the explanation, MuLVx does not appear to
bind effectively to the receptor that allows
MuLVE to infect murine cells.
Preparation and characterization of VSV
pseudotypes with a MuLVx coat. To more di-
rectly analyze the ability of MuLVx to pene-
trate different cells, VSV(MuLVx) was pro-
duced. Two classes of MuLVx have been found
and classified (3, 7, 38). They differ with respect
to their nucleic acid sequences and the immu-
nological type specificity in their structural
protein p12. The MuLVx from NZB mice de-
scribed by Levy (23) and Levy and Pincus (26) is
referred to here as MuLVXb, and the one iso-
lated from BALB/c mice is referred to as Mu-
LVxa. We have often used them interchangea-
bly because their interference patterns appear
to be identical (16).
To investigate whether VSV(MuLVXb) was
actually produced upon superinfection of 15176
cells with VSV, the yield of VSV from these
cells was neutralized with various dilutions of
anti-VSV antiserum and then assayed on rab-
bit cells permissive for MuLVx (5). A residual
titer of about 10-4 could not be neutralized by
excess anti-VSV serum (Fig. 2). Addition of an
antiserum made against MuLVx, however, re-
duced the residual VSV titer from 10-4 to less
than 10-6, indicating that more than 100 PFU of
VSV(MuLVXb) were present. Another way to
demonstrate the VSV(MuLVx) was to titrate
this VSV(MuLVx) on either SIRC cells or SIRC
cells preinfected with MuLVx after treatment
with either anti-VSV serum or anti-VSV serum
plus anti-MuLVx serum. When the virus was
assayed on SIRC cells, the anti-MuLVx antise-
rum inactivated at least 59-fold more virus than
the VSV antiserum alone (Table 6). On SIRC
cells producing MuLVx, no reduction could be
detected. VSV(VSV) gave a fivefold higher titer
on the MuLVx-infected cells. VSV(MuLVx) is
therefore detectable in two ways: as virus that
can be interfered with by MuLVx, and as virus
that can be neutralized by anti-MuLVx antise-
rum.
To determine whether MuLVx can penetrate
mouse cells, VSV(MuLVXb) was titrated on
JLS-V9 mouse cells. On the mouse cells, the
anti-MuLVx antiserum inactivated only two-
fold more virus than the VSV antiserum alone
(Table 6). It appears, therefore, that MuLVXb is
restricted at the cell surface in mouse cells.
VSV(MuLVXa) was made by superinfecting
SIRC cells producing MuLVxa with VSV. With
this preparation, a set of experiments similar to
those described above for VSV(MuLVXb) was
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performed using mink cells as permissive cells
and NIH/3T3 mouse cells (Table 7). The titer of
VSV(MuLVxa) was 350-fold above the back-
ground of the doubly neutralized sample on the
permissive mink cells. Mouse cells showed a
fivefold lower titer after double neutralization
than after anti-VSV treatment alone. The re-
I010°_
1/80 /40 /20
Antiserum dilution
FIG. 2. Demonstration of VSV(MuLVx) on rabbit
cells. Human 15176 cells producing MuLVXb were
superinfected with VSV at a multiplicity of infection
..of2 to 4. The virus was adsorbed for 45 min at 370C
(1 ml/10-cm dish), and then 9 ml of medium was
added. The virus yield was harvested after 14 h of
incubation at 370C. Aliquots were neutralized with
different concentrations of anti-VSV antiserum as
described in Materials and Methods. The remaining
fraction of VSV was determined in a VSV plaque
assay on SIRC cells as indicator cells at 370C (0).
Some samples were neutralized with anti-VSV anti-
serum as indicated and with anti-MuLVx antiserum
at a concentration of1/40, and the remaining fraction
of VSV was determined as above (0).
ceptor concentration for MuLVxa on mink cells
and for MuLVXb on SIRC cells was much higher
than on mouse cells, but some receptors on
mouse cells appeared to exist (Table 7). We do
not know whether these apparent receptors on
mouse cells were due to a contaminating pseu-
dotype, low levels ofMuLVx receptors on mouse
cells, or an experimental artifact.
Restriction of VSV(MuLVE) on xenogeneic
cells. To determine whether xenogeneic cells
restrict growth of MuLVE at the level of pene-
tration or as an intracellular event, rat, mink,
rabbit, and mouse cells were infected with
VSV(M-MuLVE) (Table 8). The VSV(M-
MuLVE) pseudotype was made by using VSV
t117 and heat inactivation of VSV(VSV) (Fig.
1). The titer of VSV(M-MuLVE) neutralized
with antiserum made against M-MuLVE was
reduced by 104 for NIH/3T3 cells, 102 for NRK
cells, 2.2 for mink cells, and 1.1 for rabbit cells.
It thus appears that the pseudotypes were se-
verely restricted at the level of penetration in
mink and rabbit cells. The reduced susceptibil-
ity ofNRK cells to VSV(M-MuLVE) appeared to
be concordant with the observed reduced sus-
ceptibility to M-MuLV (28; E. Rothenberg, un-
published observations).
Phenotypic mixing between MuLVE and
MuLVx. To further characterize the penetra-
tion block of mouse cells and xenogeneic cells
toward MuLVx and MuLVE, respectively, we
made pseudotypes between MuLVE and
MuLV,. Phenotypic mixing has been observed
to occur very readily between different sub-
groups of the avian leukosis viruses (41). Simi-
larly, phenotypic mixing might be expected if
cells were producing MuLVE and MuLVx si-
multaneously. JLS-V9 cells, upon induction
with halogenated pyrimidines, produced 3 x
TABLE 6. Host restriction of VSV(MuLVXb) in homogeneic and xenogeneic cells
PFU/ml after given antibody treatment
Indicator cells Ratio anti-VSV/(anti-VSV
None Anti-VSV Anti-VSV and and anti-MuLVx)
anti-MuLVx
SIRC producing MuLVxa 20 x 107 40 40 1
SIRC 4 x 107 590 .10 59
JLS-V9 20 x 107 130 80 1.6
TABLE 7. Host restriction of VSV(MuLVxa) in mouse cells
PFU/ml after given antibody treatment
Indicator cells Ratio anti-VSV/(anti-VSV
None Anti-VSV Anti-VSV and and anti-MuLVx)
anti-MuLVx
Mink (CCL64) 2.3 x 108 7 x 103 20 350
Mouse (NIH) 7.2 x 107 110 20 5.5
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TABLE 8. Host restriction of VSVtl1 7(M-MuLVE) in
xenogeneic and homogeneic cells
PFU/ml after given anti-
body treatment Ratio none/
Indicator cells anti- M-
anti-M- MuLVE
None MULVE
Mouse (NIH) 1.5 x 105 10 1.5 x 104
Rat (NRK) 1.1 x 103 10 1.1 x 102
Mink (CCL64) 5.3 x 102 2.4 x 102 2.2
Rabbit (SIRC) 3.4 x 102 2.6 x 102 1.3
105 PFU/ml of MuLVx (Table 4). JLS-V11 cells
are JLS-V9 cells chronically infected with M-
MuLVE (45). They are producing 106 PFU/ml of
MuLVE. Upon induction with BUdR, these
JLS-V11 cells produced 106 PFU/ml of MuLVE
and 3 x 105 PFU/ml of MuLVx. BUdR-induced
JLS-V11 cells therefore produce similar titers of
MuLVE and MuLVx, a situation in which phe-
notypic mixing is expected. It appears that in-
duction of MuLVx by BUdR in JLS-V11 cells
does not affect their production ofM-MuLVE.
MuLVE(MuLVx) pseudotypes were sought in
the following way. SIRC cells and SIRC cells
already producing MuLVx were infected with
the yield from BUdR-treated JLS-V11 cells con-
taining the presumptive MuLVE(MuLVx) pseu-
dotypes. Both types of cells were also infected
with pure MuLVE as a control. Five days after
the infections the number of infective centers
producing MuLVE was determined, and 12 days
after infection the yield of MuLVE produced by
these infected SIRC cell cultures was deter-
mined (Table 9). The SIRC cells infected with
the presumptive MuLVE(MuLVx) produced a
titer of 104 PFU/ml of MuLVE as assayed on
mouse cells, and more than 50% of the cells
were scored as infective centers for MuLVE.
SIRC cells producing MuLVx could not be in-
fected by the MuLVE(MuLVx), nor did pure
MuLVE infect the rabbit cells. Experiments
carried out with mink cells gave essentially the
same result.
Thus the MuLVE(MuLVx) appears to exist
and to allow the MuLVE genome to be estab-
lished in xenogeneic cells. Cells infected by the
pseudotype produce virus that grows on mouse
cells and therefore has the phenotype of an
MuLVE. Xenogeneic cells that are already pro-
ducing MuLVx interfere with the superinfec-
tion of MuLVE(MuLVx). MuLVE provided with
an MuLVx envelope can thus pass the penetra-
tion block otherwise exerted towards MuLVE-
(MuLVE). An interesting observation was made
in the course ofthese experiments. It was found
that MuLVE growing in xenogeneic cells causes
syncytia formation with XC cells. MuLVx can
therefore easily be distinguished from MuLVE
because it is negative in an XC cell assay. We
thus could measure MuLVE(MuLVx) directly in
a conventional XC assay on rabbit and mink
cells, since the MuLVE genome can only get
into xenogeneic cells if it is provided with an
MuLVx envelope as described above. On rabbit
cells as well as on mink cells, a titer of approxi-
mately 104 XC PFU was observed. These re-
sults again showed that phenotypic mixing is a
very efficient process (Table 10).
MuLVx(MuLVE) pseudotypes were then
sought in the following way. NIH/3T3 cells,
SIM.R cells, and NIH/3T3 cells producing M-
MuLVE were infected with the yield from
TABLE 9. Infection of rabbit cells with
MuLVE(MuLVx) pseudotypes
XC assay on NIH/3T3
Virus used for in- cells
Cells fection Infective PFU/ml
centers (% FUm
SIRC MuLVE(MuLVx)a >50 2 x 104
SIRC pro- MuLVE(MuLVx) - <10
ducing
MuLVx
SIRC MuLVE (pure) - <10
a Presumptive phenotypic mixture containing
MuLVE(MuLVx), MuLVx(MuLVE), MuLVE, and MuLVx.
TABLE 10. XC assay ofMuLVE(MuLVx) on rabbit
and mink cells
Prepn used to infect
Assay cells Virus
(result Virus detected from
scored) MuLV duced
JLS-V11
cells
Cat S+L- MuLVx 0 3 x 105
(FFU/ml)
Rabbit (XC MuLVE(MuLVx) 0 1.5 x 104
plaques/ml)
Mink (XC MuLVE(MuLVx) 0 2 x 104
plaques/ml)
NIH/3T3 (XC MuLVE 4 x 106 3 x 106
plaques/ml)
a For XC assays on SIRC indicator cells, 105 cells/5-cm
dish were plated. The following day the cultures were in-
fected with virus in 8 g&g of polybrene per ml. On day 2 after
infection the medium was changed, and on day 4 the cul-
tures were UV irradiated and overlaid with 2 x 106 cells.
For XC assays on mink cells, 5 x 104 cells/5-cm dish were
plated. The following day the cultures were infected with
virus in medium containing 8 ,ug of polybrene per ml. On
day 2 after infection the medium was changed, and on day 3
or 4 the cultures were UV irradiated and overlaid with 2 x
106 cells/5-cm dish. For the SIRC as well as the mink XC
assay, the cultures were fixed and stained on day 7 after
infection.
J. VIROL.
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BUdR-induced JLS-V11 cells and with
MuLVE(MuLVE) as control. After 5 days, the
titers of MuLVx and MuLVE were determined
(Table 11). All cultures produced similar
amounts of M-MuLV as determined by XC as-
say on NIH/3T3 cells. NIH/3T3 cells infected
with the presumptive MuLVx(MuLVE) pseudo-
types produced 3 x 103 FFU/ml of virus having
an MuLVx phenotype as determined by the cat
S+L- focus assay. NIH/3T3 cells infected with
M-MuLVE did not produce any MuLVx. NIH/
3T3 cells already producing M-MuLVE did not
produce detectable MuLVx after superinfection
with the putative MuLVx(MuLVE). MuLVx
provided with an MuLVE envelope can thus
pass the penetration block otherwise exerted
towards MuLVx in mouse cells. Subsequently,
these cells will produce virus that has the phe-
notype of MuLV,.
The amounts ofMuLVx produced by NIH/3T3
cells and SIM.R cells infected with MuLVx(M-
MuLVE) (M-MuLVE being an NB-tropic M-
MuLV) were not significantly different. NIH/
3T3 cells and SIM.R cells differ with respect to
their Fv-1 locus (29, 30): NIH/3T3 cells have the
Fv-1" allele and SIM.R cells have the Fv-lb
allele (42). It therefore appears that the Fv-1
locus does not affect the establishment of an
infection by MuLVx in mouse cells if these cells
were infected by a phenotypic mixture of an
NB-tropic MuLVE and MuLVx.
DISCUSSION
These results as well as extensive previous
work from a number of laboratories delineate
two distinct classes of retroviruses of inbred
mice. One class is the ecotropic viruses, those
that can infect mouse cells. The other class is
the xenotropic viruses, those that can infect
cells of other species (2, 5, 23-26). Both classes
of viruses are considered to be murine viruses
because they can be recovered from uninfected
mice and their DNA appears to be inherited as
part of the genome of murine cells. They all
TABLE 11. Infection of mouse cells with
MuLVx(MuLVd) pseudotypes
MuLVx MuLVE
Cells V trisusd for infe- titer titertion (FFU/ml) (PFU/ml)
NIH/3T3 MuLVx(MuLVE)a 3 x 103 3 x 105
SIM.R MULVx(MuLVE)a 4 x 103 9 x 104
NIH/3T3 MuLVX(MuLVE)a 3 7 x 105
producing
M-MuLVE
NIH/3T3 M-MuLVE (pure) 0 3 x 105
SIM.R M-MuLVE (pure) 0 lop
a Presumptive phenotypic mixture containing MuLVx-
(MuLVE), MuLVE(MuLVx), MULVE, and MuLVx.
have murine group-specific antigenic determi-
nants (39).
The major difference between the ecotropic
and xenotropic murine viruses from our results,
as well as those of Levy (23) and Fischinger et
al. (13), appears to be the type of cell surface
receptor used by the virus in the initial steps of
infection. The mouse fibroblast cells we have
tested have receptors available for the ecotropic
viruses but few if any for xenotropic viruses;
cells of rabbit, mink, and other species have
receptors for xenotropic virus but few if any
receptors for ecotropic viruses. Our evidence for
receptors on a given cell comes mainly from
studies using VSV pseudotypes with an appro-
priate MuLV-derived coat. VSV(MuLVE) in-
fects mouse cells but not cells of other species
(18, 46). VSV(MuLVx) infects cells of rabbit and
mink but infects poorly, if at all, cells from
mice.
Murine ecotropic viruses interfere with each
other at the cell surface, presumably by compe-
tition for a limited number of surface receptor
sites (32, 36, 37). Viruses that bind to the recep-
tors, even if they cannot infect mouse cells,
would be expected to interfere with MuLVE.
Therefore, the ability of MuLVx-producing
mouse cells, such as the IUdR-induced JLS-V9
cells, to be infected by an MuLVE is evidence
that the MuLVE receptor cannot even bind
MuLVx and that MuLVx receptors must be dis-
tinctly different from MuLVE receptors. Even if
some of the cells in the MuLVx-producing cul-
tures were not producing virus, the large
amount of infectious MuLVx in the culture me-
dium should have blocked all the available re-
ceptors if the MuLVE receptor could bind
MuLVx.
The phenotypic mixing experiments de-
scribed here show that MuLVE provided with
an MuLVx envelope will penetrate and estab-
lish an infection in xenogeneic cells and that
MuLVx can infect mouse cells ifprovided with a
MuLVE envelope. These pseudotypes penetrate
the cells, using the receptors corresponding to
the envelope of the virus particle, as demon-
strated by interference experiments. The
MuLVx genome does not appear to be sensitive
to the intracellular restriction exerted by the
products of either the Fv-ln or Fv-lb alleles.
Results in agreement with ours about pheno-
typic mixing between MuLVE and MuLVx were
obtained independently by A. Ishimoto and W.
P. Rowe (personal communication).
The penetration block exerted by mouse cells
towards MuLVx could either be due to the lack
of MuLVx-specific receptors on mouse cells or
possibly to the production of MuLVx glycopro-
tein by mouse cells that then could block
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MuLVx-specific receptors in a fashion reminis-
cent of the restriction of the subgroup E avian
leukosis viruses on chf+ cells (43). Small
amounts of MuLVx glycoprotein have been
found on the mouse fibroblasts from the strains
used in these experiments (17). It is not clear
whether the amount of glycoprotein formed by
these cells could be sufficient to cause signifi-
cant interference. The experiments with VSV
pseudotypes suggest that mouse cells may have
a small number of MuLVx receptors, and one
mouse cell line, derived from a wild mouse, has
receptors for MuLVx (15). The possibility that
most or all mouse cells do have MuLVx recep-
tors but that they are usually blocked by syn-
thesis of endogenous MuLVx glycoprotein must
therefore be seriously considered.
The observation by Scolnick and Parks (33)
and by Gazdar et al. (14) that MuLVx is re-
stricted in a dominant fashion in mouse fibro-
blasts would agree well with such an explana-
tion.
A different approach to determine MuLVE
receptors on cell surfaces was reported recently
by De Larco and Todaro (8), who measured
binding of radiolabeled glycoprotein of eco-
tropic viruses to various cells. Their results and
ours using VSV pseudotypes are in agreement.
There have been reports that mouse viruses
can be grown on human cells (1, 4, 44). In view
of the results presented here, those reports are
best explained by phenotypic mixing of MuLVx
with MuLVE in the virus stocks that were used.
The MuLVx envelope thus can serve as a vehi-
cle for either the MSV or the MuLVE genome in
interspecies viral transfer.
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ADDENDUM IN PROOF
In a recent publication Hartley and Rowe also
describe the lack of interference between MuLVE
and MuLVx (J. W. Hartley and W. P. Rowe, J.
Virol. 19:19-25, 1976).
LITERATURE CITED
1. Aaronson, S. A. 1971. Common genetic alteration of
RNA tumor viruses grown in human cells. Nature
(London) 230:445-449.
2. Aaronson, S. A., and J. R. Stephenson. 1973. Independ-
ent segregation of loci for activation of biologically
distinguishable RNA C-type viruses in mouse cells.
Proc. Natl. Acad. Sci. U.S.A. 70:2055-2058.
3. Aaronson, S. A., and J. R. Stephenson. 1974. Differen-
tial cellular regulation of three distinct classes of
type-C RNA viruses endogenous to mouse cells. Cold
Spring Harbor Symp. Quant. Biol. 39:1129-1137.
4. Ablashi, D. V., W. Turner, G. R. Armstrong, and L.R.
Bass. 1972. Characterization of murine Rauscher leu-
kemia virus propagated in human cells. J. Natl. Can-
cer Inst. 48:615-621.
5. Benveniste, R. E., M. M. Lieber, and G. J. Todaro.
1974. A distinct class of inducible murine type C
viruses which replicate in the rabbit SIRC cell line.
Proc. Natl. Acad. Sci. U.S.A. 71:602-606.
6. Besmer, P., D. Smotkin, W. Haseltine, H. Fan, A. T.
Wilson, M. Paskind, R. Weinberg, and D. Baltimore.
1974. Mechanism of induction of RNA tumor viruses
by halogenated pyrimidines. Cold Spring Harbor
Symp. Quant. Biol. 39:1103-1107.
7. Callahan, R. C., M. M. Lieber, and G. J. Todaro. 1975.
Nucleic acid homology of murine xenotropic type C
viruses. J. Virol. 15:1378-1384.
8. De Larco, J., and G. J. Todaro. 1976. Membrane recep-
tors for murine leukemia viruses: characterization
using the purified viral envelope glycoprotein gp 71.
Cell 8:365-371.
9. Duc-Nguyen, H., E. N. Rosenblum, and R. F. Zeigel.
1966. Persistent infection of a rat kidney cell line with
Rauscher murine leukemia virus. J. Bacteriol.
92:1133-1140.
10. Fan, H., and P. Besmer. 1975. RNA metabolism of
murine leukemia virus. II. Endogenous virus-specific
RNA in the uninfected BALB/c cell line JLS-V9. J.
Virol. 15:836-842.
11. Fan, H., and M. Paskind. 1974. Measurement of the
complexity of cloned Moloney murine leukemia virus:
evidence for a haploid genome. J. Virol. 14:421-429.
12. Fischinger, P. J., C. S. Blevins, and S. Nomura. 1974.
Simple quantitative assay for both xenotropic murine
leukemia and ecotropic feline leukemia viruses. J.
Virol. 14:177-179.
13. Fischinger, P. J., S. Nomura, C. S. Blevins, and D. P.
Bolognesi. 1975. Two levels of restriction by mouse or
cat cells of murine sarcoma virus coated by endoge-
nous xenotropic oncornavirus. J. Gen. Virol. 29:51-
62.
14. Gazdar, A. F., E. K. Russell, and J. D. Minna. 1974.
Replication of mouse tropic and xenotropic strains of
murine leukemia virus in human x mouse hybrid
cells. Proc. Natl. Acad. Sci. U.S.A. 71:2642-2645.
15. Hartley, J. W., and W. P. Rowe. 1975. Clonal cell lines
from a feral mouse embryo which lack host-range
restrictions for murine leukemia viruses. Virology
65:128-134.
16. Henderson, I. C., M. M. Lieber, and G. J. Todaro. 1974.
Mink cell line Ml/Lu (CCL64). Focus formation and
the generation of "nonproducer" transformed cell
lines with murine and feline sarcoma viruses. Virol-
ogy 60:282-287.
17. Hino, S., J. R. Stephenson, and S. A. Aaronson. 1976.
Radioimmunoassays for the 70,000-molecular-weight
glycoproteins of endogenous mouse type C viruses:
viral antigen expression in normal mouse tissues and
sera. J. Virol. 18:933-941.
18. Huang, A. S., P. Besmer, L. Chu, and D. Baltimore.
1973. Growth of pseudotypes of vesicular stomatitis
virus with N-tropic murine leukemia virus coats in
cells resistant to N-tropic viruses. J. Virol. 12:659-
662.
19. Jainchill, J. L., S. A. Aaronson, and G. J. Todaro. 1969.
Murine sarcoma and leukemia viruses: assay using
J. VIROL.
MECHANISM OF RESTRICTION OF TWO MuLV'S 973
clonal lines of contact inhibited mouse cells. J. Virol.
4:549-553.
20. Jolicoeur, P., and D. Baltimore. 1975. Effect ofthe Fv-1
locus on the titration of murine leukemia viruses. J.
Virol. 16:1593-1598.
21. Jolicoeur, P., and D. Baltimore. 1976. Effect ofthe Fv-1
gene product on proviral DNA formation and integra-
tion in cells infected with murine leukemia virus.
Proc. Natl. Acad. Sci. U.S.A. 73:2236-2240.
22. Krontiris, T. G., R. Soeiro, and B. N. Fields. 1973. Host
restriction of Friend leukemia virus. Role of the viral
outer coat. Proc. Natl. Acad. Sci. U.S.A. 70:2549-
2553.
23. Levy, J. A. 1973. Xenotropic viruses: murine leukemia
viruses associated with NIH Swiss, NZB and other
mouse strains. Science 182:1151-1153.
24. Levy, J. A. 1975. Host range of murine xenotropic virus
replication in avian cells. Nature (London) 253:140-
142.
25. Levy, J. A., P. Kazan, 0. Varnier, and H. Kleiman.
1975. Murine xenotropic type C viruses. I. Distribu-
tion and further characterization of the virus in NZB
mice. J. Virol. 16:844-853.
26. Levy, J. A., and T. Pincus. 1970. Demonstration of
biological activity of a murine leukemia virus of New
Zealand black mice. Science 170:326-327.
27. Meuth, M., and H. Green. 1974. Induction of a deoxycy-
tidineless state in cultured mammalian cells by bro-
modeoxyuridine. Cell 2:109.
28. Parkman, R., J. A. Levy, and R. C. Ting. 1970. Murine
sarcoma virus: the question of defectiveness. Science
168:387-389.
29. Pincus, T., J. W. Hartley, and W. P. Rowe. 1971. A
major genetic locus affecting resistance to infection
with murine leukemia viruses. I. Tissue culture stud-
ies of naturally occurring viruses. J. Exp. Med.
133:1219-1233.
30. Pincus, T., W. P. Rowe, and F. Lilly. 1971. A major
genetic locus affecting resistance to infection with
murine leukemia viruses. II. Apparent identity to a
major locus described for resistance to Friend murine
leukemia virus. J. Exp. Med. 133:1234-1241.
31. Rowe, W. P., W. E. Pugh, and J. W. Hartley. 1970.
Plaque assay techniques for murine leukemia vi-
ruses. Virology 42:1136-1139.
32. Sarma, P. S., M. Cheong, J. W. Hartley, and R. J.
Huebner. 1967. A viral interference test for mouse
leukemia viruses. Virology 33:180-184.
33. Scolnick, E. M., and W. P. Parks. 1974. Host range
studies on xenotropic type C viruses in somatic cell
hybrids. Virology 59:168-178.
34. Stampfer, M., D. Baltimore, and A. S. Huang. 1969.
Ribonucleic acid synthesis of vesicular stomatitis vi-
rus. I. Species of ribonucleic acid found in Chinese
hamster ovary cells infected with plaque-forming and
defective particles. J. Virol. 4:154-161.
35. Stampfer, M., D. Baltimore, and A. S. Huang. 1971.
Absence of interference during high-multiplicity in-
fection by clonally purified vesicular stomatitis virus.
J. Virol. 7:409-411.
36. Steck, F. T., and H. Rubin. 1966. The mechanism of
interference between avian leukosis virus and Rous
sarcoma virus. I. Establishment of interference. Vi-
rology 29:628-641.
37. Steck, F. T., and H. Rubin. 1966. The mechanism of
interference between avian leukosis virus and Rous
sarcoma virus. II. Early steps of infection by RSV of
cells under conditions of interference. Virology
29:642-653.
38. Stephenson, J. R., S. A. Aaronson, P. Arnstein, R. J.
Huebner, and S. R. Tronick. 1974. Demonstration of
two immunologically distinct xenotropic type C RNA
viruses of mouse cells. Virology 61:56-63.
39. Stephenson, J. R., S. R. Tronick, and S. A. Aaronson.
1974. Analysis of type specific antigenic determinants
of two structural polypeptides of mouse RNA type C
viruses. Virology 58:1-8.
40. Svoboda, J., P. 0. Chyle, D. Simkovic, and I. Hilgert.
1963. Demonstration of the absence of infectious Rous
virus in rat tumor XC whose structurally intact cells
produce Rous sarcoma when transferred to chicks.
Folia Biol. (Prague) 9:77-81.
41. Vogt, P. K. 1967. Phenotypic mixing in the avian tumor
virus group. Virology 32:708-717.
42. Ware, L. M., and A. A. Axelrad. 1972. Inherited resist-
ance to N- and B-tropic murine leukemia viruses in
vitro: evidence that congenic mouse strains SIM and
SIM.R differ at the Fv-1 locus. Virology 50:339-348.
43. Weiss, R. A., D. Boettiger, and D. S. Love. 1974. Phe-
notypic mixing between vesicular stomatitis virus
and avian RNA tumor viruses. Cold Spring Harbor
Symp. Quant. Biol. 39:913-918.
44. Wright, B. S., and W. Korol. 1969. Infection of human
embryonic cell cultures with Rauscher murine leuke-
mia virus. Cancer Res. 29:1886-1888.
45. Wright, B. S., P. A. O'Brien, G. P. Shibley, S. A.
Mayyasi, and J. G. Lasfargues. 1967. Infection of an
established mouse bone marrow cell line (JLS-V9)
with Rauscher and Moloney murine leukemia vi-
ruses. Cancer Res. 27:1672-1677.
46. Zavada, J. 1972. Pseudotypes of vesicular stomatitis
virus with the coat of murine leukemia and avian
myeloblastosis viruses. J. Gen. Virol. 15:183-191.
47. Zavada, J. 1972. VSV pseudotype particles with the coat
of avian myeloblastosis virus. Nature (London) New
Biol. 240:122-128.
VOL. 21, 1977
